Regionally selective changes in neurotransmitter receptors in the brain of the 5-HT1B knockout mouse

Journal of Chemical Neuroanatomy

Volumn 35, Issue 4, 2008, Pages 356-363

  Ase, A R ^a   Reader, T A ^a   Hen, R ^b   Descarries, L ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Columbia University ^*  (United States)

Author keywords

Dopamine receptors; Dopamine transporter; GABA receptors; Opioid receptors; Psychostimulants

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID ISOPROPYL ESTER; 4 AMINOBUTYRIC ACID B RECEPTOR; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BACLOFEN; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MU OPIATE RECEPTOR; NEUROTRANSMITTER RECEPTOR; PSYCHOSTIMULANT AGENT; QUINPIROLE; RACLOPRIDE; SEROTONIN 1B RECEPTOR; SULFUR 35; TRITIUM;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; GABAERGIC SYSTEM; KNOCKOUT GENE; LIGAND BINDING; MALE; MOUSE; NEOCORTEX; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; PRIORITY JOURNAL;

ANIMALS; BINDING SITES; BINDING, COMPETITIVE; BRAIN; BRAIN CHEMISTRY; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; MALE; MICE; MICE, KNOCKOUT; NEUROTRANSMITTER AGENTS; RADIOLIGAND ASSAY; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GABA-B; RECEPTORS, NEUROTRANSMITTER; RECEPTORS, OPIOID, MU; SEROTONIN;

EID: 43649085197     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2008.02.007     Document Type: Article

References (77)

1. 1B receptor knockout mice. J. Neurochem. 75 (2000) 2415-2426
2. 1B knockout. J. Neurochem. 78 (2001) 619-630
3. 1B knockout mouse. Neuropharmacology 42 (2002) 941-949
4. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner D., Heils A., Mössner R., Westphal H., and Lesch K.P. Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("Extasy") in serotonin transporter-deficient mice. Mol. Pharmacol. 53 (1998) 649-655
5. Benoit-Marand M., Borrelli E., and Gonon F. Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J. Neurosci. 21 (2001) 9134-9141
6. 2 antagonists. Behav. Pharmacol. 1 (1990) 355-363
7. Bonaventure P., Voorn P., Luyten W.H., Jurzak M., Schotte A., and Leysen J.E. Detailed mapping of serotonin 5-HT1B and 5-HT1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function. Neuroscience 82 (1998) 469-484
8. Boschert U., Amara D.A., Segu L., and Hen R. The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience 58 (1994) 167-182
9. B agonist CGP 44532 decreases cocaine self-administration in rats: demonstration using a progressive ratio and a discrete trials procedure. Neuropharmacology 38 (1999) 1797-1804
10. Brebner K., Phelan R., and Roberts D.C. Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement. Pharmacol. Biochem. Behav. 66 (2000) 857-862
11. 1B knockout mice: effects of injection route on acute and sensitized responses. Behav. Pharmacol. 12 (2001) 549-555
12. Brunner D., and Hen R. Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice. Ann. N.Y. Acad. Sci. 836 (1997) 81-105
13. Caine S.B., and Koob G.F. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J. Pharm. Exp. Ther. 270 (1994) 209-218
14. Campbell U.C., Lac S.T., and Carroll M.E. Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology 143 (1999) 209-214
15. Castañon N., Scearce-Levie K., Lucas J.J., Rocha B., and Hen R. Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists. Pharmacol. Biochem. Behav. 67 (2000) 559-566
16. Corrigall W.A., Coen K.M., Adamson K.L., and Chow B.L. The mu opioid agonist DAMGO alters the intravenous self-administration of cocaine in rats: mechanisms in the ventral tegmental area. Psychopharmacology 141 (1999) 428-435
17. Descarries L., and Beaudet A. The use of radioautography for investigating transmitter-specific neurons. In: Björklund A., and Hökfelt T. (Eds). Handbook of Chemical Neuroanatomy. Vol. I-Methods (1983), Elsevier, North-Holland, Amsterdam 286-364
18. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38 (1995) 95-137
19. Doucet E., Pohl M., Fattaccini C.M., Adrien J., El Mestikawy S., and Hamon M. In situ hybridization evidence for the synthesis of 5-HT1B receptor in serotoninergic neurons of anterior raphe nuclei in the rat brain. Synapse 19 (1995) 18-28
20. Franklin K.B.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press, San Diego, CA/London, UK
21. Fremeau R.T., Duncan G.E., Fornaretto M.-G., Dearry A., Gingrich J.A., Breese G.R., and Caron M.G. Localization of D1 receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. PNAS, USA 88 (1991) 3772-3776
22. Graeff F.G., Viana M.B., and Mora P.O. Dual role of 5-HT in defense and anxiety. Neurosci. Behav. Rev. 21 (1997) 791-799
23. He L., Di Monte D.A., Langston J.W., and Quik M. Autoradiographic analysis of dopamine receptor-stimulated [(35)S]GTPgammaS binding in rat striatum. Brain Res. 885 (2000) 133-136
24. Huang Y.Y., and Kandel E.R. Postsynaptic induction and PKA-dependent expression of LTP in the lateral amygdala. Neuron 21 (1998) 169-178
25. Izenwasser S., Heller B., and Cox B.M. Continuous cocaine administration enhances mu- but not delta-opioid receptor-mediated inhibition of adenylyl cyclase activity in nucleus accumbens. Eur. J. Pharmacol. 297 (1996) 187-191
26. Johnson S.W., and North R.A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol. 450 (1992) 455-468
27. Koob G.F., and Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science 242 (1988) 715-723
28. Koob G.F., Le H.T., and Creese I. The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci. Lett. 79 (1987) 315-320
29. Kuhar M.J., Ritz M.C., and Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14 (1991) 299-302
30. 35S-GTPγS binding. Life Sci. 69 (2001) 1093-1102
31. 3 receptor-dependent G protein activation in rat brain sections. J. Neurochem. 71 (1998) 808-816
32. Lucas J.J., Segu L., and Hen R. 5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptamine1B knockout mice and the 5-hydroxytryptamine1B/1D antagonist GR127935. Mol. Pharmacol. 51 (1997) 755-763
33. Maher C.E., Selley D.E., and Childers S.R. Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions. Biochem. Pharmacol. 59 (2000) 1395-1401
34. 2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J. Neurosci. 10 (1990) 2587-2600
35. McKernan M.G., and Shinnick-Gallagher P. Fear conditioning induces a lasting potentiation of synaptic currents in vitro. Nature 390 (1997) 607-611
36. Meador-Woodruff J.H., Mansour A., Healy D.J., Kuehn R., Zhou Q.Y., Bunzow J.R., Akil H., Civelli O., and Watson Jr. S.J. Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology 5 (1991) 231-242
37. 2 receptor in the rat brain by in situ hybridization histochemistry. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 8560-8564
38. Moga M.M., Weis R.P., and Moore R.Y. Efferent projections of the paraventricular thalamic nucleus in the rat. J. Comp. Neurol. 359 (1995) 221-238
39. Nestler E.J. Molecular mechanisms of opiate and cocaine addiction. Curr. Opin. Neurobiol. 7 (1997) 713-719
40. Nestler E.J., Terwilliger R.Z., Walker J.R., Sevarino K.A., and Duman R.S. Chronic cocaine treatment decreases levels of the G protein subunits Gi alpha and Go alpha in discrete regions of rat brain. J. Neurochem. 55 (1990) 1079-1082
41. 2 receptors in the forebrain of dystonia musculorum mutant mice: an autoradiographic survey in relation to dopamine contents. Synapse 37 (2000) 1-15
42. Park Y., Ma T., Tanaka S., Jang C., Loh H.H., Ko K.H., and Ho I.K. Comparison of G-protein activation in the brain by mu-, delta-, and kappa-opioid receptor agonists in mu-opioid receptor knockout mice. Brain Res. Bull. 52 (2000) 297-302
43. Phillips T.J., Hen R., and Crabbe J.C. Complications associated with genetic background effects in research using knockout mice. Psychopharmacology 147 (1999) 5-7
44. Pickard G.E., Weber E.T., Scott P.A., Riberdy A.F., and Rea M.A. 5-HT1B receptor agonists inhibit light-induced phase shifts of behavioral circadian rhythms and expression of the immediate-early gene c-fos in the suprachiasmatic nucleus. J. Neurosci. 16 (1996) 8208-8220
45. Pickard G.E., Smith B.N., Belenky M., Rea M.A., Dudek F.E., and Sollars P.J. 5-HT1B receptor-mediated presynaptic inhibition of retinal input to the suprachiasmatic nucleus. J. Neurosci. 19 (1999) 4034-4045
46. Reader T.A., and Strazielle C. Quantitative autoradiography of monoamine uptake sites and receptors in rat and mouse brain. In: Boulton A.A., Baker G.B., and Bateson A.N. (Eds). Neuromethods, Vol. 33: Cell Neurobiology Techniques (1999), Humana Press, Totowa, NJ 1-51
47. Riad M., Garcia S., Watkins K.C., Jodoin N., Doucet E., Langlois X., El Mestikawy S., Hamon M., and Descarries L. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J. Comp. Neurol. 417 (2000) 181-194
48. Ritz M.C., Lamb R.J., Goldberg S.R., and Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237 (1987) 1219-1223
49. Roberts D.C., Andrews M.M., and Vickers G.J. Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 15 (1996) 417-423
50. Roberts D.C., and Andrews M.M. Baclofen suppression of cocaine self-administration: Phillips T.J., Hen R., Crabbe J.C. (1999) Complications associated with genetic background effects in research using knockout mice. Psychopharmacology 147 (1997) 5-7
51. Rocha B.A., Ator R., Emmett-Oglesby M.W., and Hen R. Intravenous cocaine self-administration in mice lacking 5-HT1B receptors. Pharmacol. Biochem. Behav. 57 (1997) 407-412
52. Rocha B.A., Scearce-Levi K., Lucas J.J., Hiroi N., Castañon N., Crabbe J.C., Nestler E.J., and Hen R. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature 393 (1998) 175-178
53. Rogan M.T., Staubli U.V., and LeDoux J.E. Fear conditioning induces associative long-term potentiation in the amygdala. Nature 390 (1997) 604-607
54. Salazar-Juárez A., Escobar C., and Aguilar-Roblero R. Anterior paraventricular thalamus modulates light-induced phase shifts in circadian rhythmicity in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 (2002) R897-R904
55. 1B receptors: from protein to physiological function and behavior. Neurosci. Behav. Rev. 28 (2004) 565-582
56. 1B receptor. Science 265 (1994) 1875-1878
57. 35S]GTPγS binding in rat brain. Synapse 47 (2003) 26-32
58. 2-receptor like immunoreactivity in midbrain dopamine neurons and their striatal targets. J. Neurosci. 14 (1994) 88-106
59. Sharpe L.G., Pilotte N.S., Shippenberg T.S., Goodman C.B., and London E.D. Autoradiographic evidence that prolonged withdrawal from intermittent cocaine reduces mu-opioid receptor expression in limbic regions of the rat brain. Synapse 37 (2000) 292-297
60. Shippenberg T.S., Hen R., and He M. Region-specific enhancement of basal extracellular and cocaine-evoked dopamine levels following constitutive deletion of the serotonin1B receptor. J. Neurochem. 75 (2000) 258-265
61. Shoaib M., Swanner L.S., Beyer C.E., Goldberg S.R., and Schindler C.W. The GABAB agonist baclofen modifies cocaine self-administration in rats. Behav. Pharmacol. 9 (1998) 195-206
62. 35S]thio]-triphosphate binding. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 7242-7246
63. 1A receptor-activated G-proteins in the rat brain. Brain Res. Bull. 44 (1997) 39-45
64. 7 receptors. J. Biol. Rhythms 16 (2001) 25-38
65. 1B receptor knockout mice exhibit an enhanced response to constant light. J. Biol. Rhythms 17 (2002) 428-437
66. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., Lesch K.P., Murphy D.L., and Uhl G.R. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 7699-7704
67. Stark K.L., and Hen R. Knockout corner. Int. J. Neuropsychopharmacol. 2 (1999) 145-150
68. 125I]RTI-121 quantitative autoradiography. Neurochem. Int. 32 (1998) 61-68
69. 3H]Ultrofilm: application to multiple benzodiazepine receptors. Neurosci. Methods 6 (1982) 59-73
70. Unterwald E.M., Horne-King J., and Kreek M.J. Chronic cocaine alters brain mu opioid receptors. Brain Res. 584 (1992) 314-318
71. 1B receptor mRNA in the human brain. Synapse 56 (2005) 21-28
72. Wise R.A., and Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94 (1987) 469-492
73. Yamada J., Saitow F., Satake S., Kiyohara T., and Konishi S. GABA(B) receptor-mediated presynaptic inhibition of glutamatergic and GABAergic transmission in the basolateral amygdala. Neuropharmacology 38 (1999) 1743-1753
74. 3H]GABA release from rat ventral tegmental area slices. J. Neurochem. 79 (2001) 914-922
75. B receptors: altered coupling to G-proteins in rats sensitized to amphetamine. Neuroscience 101 (2000) 5-10
76. Zheng S.X., Bosch M.A., and Ronnekleiv O.K. mu-opioid receptor mRNA expression in identified hypothalamic neurons. J. Comp. Neurol. 487 (2005) 332-344
77. Zhu W., and Pan Z.Z. μ-Opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons. Neuroscience 133 (2005) 97-103